papaverine has been researched along with Multiple Sclerosis in 9 studies
Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.
Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
Excerpt | Relevance | Reference |
---|---|---|
"Using papaverine, papaverine/phentolamine, or prostaglandin E1 (PGE1), intracavernosal pharmacotherapy has been successful in treating erectile dysfunction." | 3.69 | Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction. ( Chao, R; Clowers, DE, 1994) |
"Intracavernous injection of papaverine was tested in a group of 29 patients with multiple sclerosis and erectile dysfunction." | 3.67 | Pharmacologically induced erection in patients with multiple sclerosis. ( Kirkeby, HJ; Petersen, T; Poulsen, EU, 1988) |
"All of the men with impotence and marked pyramidal dysfunction in their legs were found by cystometric studies to have bladder hyperreflexia." | 1.29 | Erectile dysfunction in multiple sclerosis. Associated neurological and neurophysiological deficits, and treatment of the condition. ( Betts, CD; Fowler, CG; Fowler, CJ; Jones, SJ, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sunke, R | 1 |
Bankala, R | 1 |
Thirupataiah, B | 1 |
Ramarao, EVVS | 1 |
Kumar, JS | 1 |
Doss, HM | 1 |
Medishetti, R | 1 |
Kulkarni, P | 1 |
Kapavarapu, RK | 1 |
Rasool, M | 1 |
Mudgal, J | 1 |
Mathew, JE | 1 |
Shenoy, GG | 1 |
Parsa, KVL | 1 |
Pal, M | 1 |
Betts, CD | 1 |
Jones, SJ | 1 |
Fowler, CG | 1 |
Fowler, CJ | 1 |
Chao, R | 1 |
Clowers, DE | 1 |
Yoshikawa, M | 1 |
Suzumura, A | 1 |
Tamaru, T | 1 |
Takayanagi, T | 1 |
Sawada, M | 1 |
Puolakka, VM | 1 |
Hashmat, AI | 1 |
Abrahams, J | 1 |
Fani, K | 1 |
Nostrand, I | 1 |
Kirkeby, HJ | 2 |
Petersen, T | 2 |
Poulsen, EU | 2 |
Dørup, J | 1 |
Baskett, PJ | 1 |
Armstrong, R | 1 |
1 review available for papaverine and Multiple Sclerosis
Article | Year |
---|---|
[Bladder dysfunction and sexual dysfunction and their management in patients with MS disease].
Topics: Alprostadil; Erectile Dysfunction; Female; Humans; Male; Multiple Sclerosis; Papaverine; Sexual Dysf | 1992 |
8 other studies available for papaverine and Multiple Sclerosis
Article | Year |
---|---|
InCl
Topics: Animals; Arthritis; Cyclic Nucleotide Phosphodiesterases, Type 4; Encephalomyelitis, Autoimmune, Exp | 2019 |
Erectile dysfunction in multiple sclerosis. Associated neurological and neurophysiological deficits, and treatment of the condition.
Topics: Adult; Brain Mapping; Ejaculation; Erectile Dysfunction; Evoked Potentials; Humans; Leg; Male; Middl | 1994 |
Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction.
Topics: Adult; Alprostadil; Cost-Benefit Analysis; Drug Combinations; Drug Costs; Drug Monitoring; Drug Syne | 1994 |
Effects of phosphodiesterase inhibitors on cytokine production by microglia.
Topics: 1-Methyl-3-isobutylxanthine; Amrinone; Animals; Anti-Ulcer Agents; Cilostazol; Colforsin; Dipyridamo | 1999 |
A lethal complication of papaverine-induced priapism.
Topics: Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Multiple Sclerosis; Papaverine; Penis; | 1991 |
Pharmacologically induced erection in patients with multiple sclerosis.
Topics: Adult; Humans; Injections; Male; Middle Aged; Multiple Sclerosis; Papaverine; Penile Erection; Self | 1988 |
Erectile dysfunction in multiple sclerosis.
Topics: Adult; Erectile Dysfunction; Evoked Potentials; Humans; Male; Middle Aged; Multiple Sclerosis; Papav | 1988 |
Anaesthetic problems in multiple sclerosis. Are certain agents contraindicated?
Topics: Adult; Amobarbital; Anesthesia; Anesthetics; Atropine; Female; Halothane; Humans; Levallorphan; Mepe | 1970 |